Orchestra BioMed Holdings, Inc. (OBIO) financial statements and ratios from SEC XBRL: revenue $33.48M (TTM), net margin -157.4%, revenue growth 1169.2% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $33.48M |
| Net Margin | -157.4% |
| Revenue Growth (YoY) | 1169.2% |
| EPS Growth (YoY) | -33.1% |
| FCF Growth (YoY) | -2.7% |
| Price / Book | 16.86 |
| Price / Sales | 278.67 |
| FCF Yield | -41.1% |
| Altman Z-Score | -1.56 (distress) |
| Piotroski F-Score | 6/9 |
| Sector P/E (Healthcare) | 21.6 |
OBIO overview · OBIO earnings · OBIO KPIs · OBIO investor relations · OBIO ownership · OBIO peers · OBIO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.